KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abbott Laboratories (ABT) EPS (Basic) (2016 - 2025)

Abbott Laboratories' EPS (Basic) history spans 17 years, with the latest figure at $1.01 for Q4 2025.

  • For Q4 2025, EPS (Basic) fell 80.87% year-over-year to $1.01; the TTM value through Dec 2025 reached $3.73, down 51.31%, while the annual FY2025 figure was $3.73, 51.37% down from the prior year.
  • EPS (Basic) for Q4 2025 was $1.01 at Abbott Laboratories, up from $0.94 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $5.28 in Q4 2024 and bottomed at $0.59 in Q4 2022.
  • The 5-year median for EPS (Basic) is $0.93 (2024), against an average of $1.13.
  • The largest annual shift saw EPS (Basic) skyrocketed 473.91% in 2024 before it crashed 80.87% in 2025.
  • A 5-year view of EPS (Basic) shows it stood at $1.12 in 2021, then tumbled by 47.32% to $0.59 in 2022, then skyrocketed by 55.93% to $0.92 in 2023, then surged by 473.91% to $5.28 in 2024, then plummeted by 80.87% to $1.01 in 2025.
  • Per Business Quant, the three most recent readings for ABT's EPS (Basic) are $1.01 (Q4 2025), $0.94 (Q3 2025), and $1.02 (Q2 2025).